NCT01306214 - Safety and Efficacy of BI 10773 as add-on to Insulin Regimen in Patients With Type 2 Diabetes Mellitus | Biotech Hunter

Enrollment

566

Participants

Timeline

Start Date

February 28, 2011

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions

Diabetes Mellitus, Type 2Obesity

Interventions

DRUG

Placebo

Placebo matching BI 10773 low dose

DRUG

Placebo

Placebo matching BI 10773 low dose

DRUG

Placebo

Placebo matching BI 10773 high dose

DRUG

Placebo

Placebo matching BI 10773 high dose

DRUG

BI 10773

BI 10773 low dose once daily

DRUG

BI 10773

BI 10773 high dose once daily

Trial Locations (103)

Unknown

1245.49.10005 Boehringer Ingelheim Investigational Site, Birmingham

1245.49.10011 Boehringer Ingelheim Investigational Site, Chandler

1245.49.10004 Boehringer Ingelheim Investigational Site, Tucson

1245.49.10002 Boehringer Ingelheim Investigational Site, Corona

1245.49.10013 Boehringer Ingelheim Investigational Site, El Cajon

1245.49.10030 Boehringer Ingelheim Investigational Site, Lomita

1245.49.10014 Boehringer Ingelheim Investigational Site, Spring Valley

1245.49.10019 Boehringer Ingelheim Investigational Site, Westlake Village

1245.49.10024 Boehringer Ingelheim Investigational Site, Denver

1245.49.10018 Boehringer Ingelheim Investigational Site, Hialeah

1245.49.10016 Boehringer Ingelheim Investigational Site, Miami

1245.49.10021 Boehringer Ingelheim Investigational Site, Blue Ridge

1245.49.10009 Boehringer Ingelheim Investigational Site, Chicago

1245.49.10015 Boehringer Ingelheim Investigational Site, Evansville

1245.49.10023 Boehringer Ingelheim Investigational Site, Greenville

1245.49.10007 Boehringer Ingelheim Investigational Site, Fargo

1245.49.10006 Boehringer Ingelheim Investigational Site, Columbus

1245.49.10025 Boehringer Ingelheim Investigational Site, Greer

1245.49.10022 Boehringer Ingelheim Investigational Site, Memphis

1245.49.10003 Boehringer Ingelheim Investigational Site, Austin

1245.49.10001 Boehringer Ingelheim Investigational Site, Dallas

1245.49.10031 Boehringer Ingelheim Investigational Site, Houston

1245.49.10033 Boehringer Ingelheim Investigational Site, Bountiful

1245.49.10032 Boehringer Ingelheim Investigational Site, Salt Lake City

1245.49.10026 Boehringer Ingelheim Investigational Site, Norfolk

1245.49.10020 Boehringer Ingelheim Investigational Site, Renton

1245.49.32010 Boehringer Ingelheim Investigational Site, Bonheiden

1245.49.32002 Boehringer Ingelheim Investigational Site, Edegem

1245.49.32007 Boehringer Ingelheim Investigational Site, Huy

1245.49.32014 Boehringer Ingelheim Investigational Site, Jette

1245.49.32013 Boehringer Ingelheim Investigational Site, La Louvière

1245.49.32012 Boehringer Ingelheim Investigational Site, Leuven

1245.49.59003 Boehringer Ingelheim Investigational Site, Pleven

1245.49.59004 Boehringer Ingelheim Investigational Site, Sofia

1245.49.59001 Boehringer Ingelheim Investigational Site, Stara Zagora

1245.49.57003 Boehringer Ingelheim Investigational Site, Barranquilla

1245.49.57004 Boehringer Ingelheim Investigational Site, Bogotá

1245.49.57005 Boehringer Ingelheim Investigational Site, Bogotá

1245.49.57006 Boehringer Ingelheim Investigational Site, Bogotá

1245.49.57002 Boehringer Ingelheim Investigational Site, Medellín

1245.49.42003 Boehringer Ingelheim Investigational Site, Brno

1245.49.42010 Boehringer Ingelheim Investigational Site, Brno

1245.49.42013 Boehringer Ingelheim Investigational Site, Břeclav

1245.49.42011 Boehringer Ingelheim Investigational Site, Chrudim

1245.49.42009 Boehringer Ingelheim Investigational Site, Hodonín

1245.49.42012 Boehringer Ingelheim Investigational Site, Svitavy56802

1245.49.72001 Boehringer Ingelheim Investigational Site, Kuopio

1245.49.72002 Boehringer Ingelheim Investigational Site, Oulu

1245.49.72003 Boehringer Ingelheim Investigational Site, Turku

1245.49.33001 Boehringer Ingelheim Investigational Site, Grenoble

1245.49.33011 Boehringer Ingelheim Investigational Site, Le Creusot

1245.49.33012 Boehringer Ingelheim Investigational Site, Marseille

1245.49.33003 Boehringer Ingelheim Investigational Site, Nantes

1245.49.33010 Boehringer Ingelheim Investigational Site, Narbonne

1245.49.33004 Boehringer Ingelheim Investigational Site, Pierre-Bénite

1245.49.33007 Boehringer Ingelheim Investigational Site, Point-à-Pitre Cedex

1245.49.33008 Boehringer Ingelheim Investigational Site, Saint-Priest-en-Jarez

1245.49.33009 Boehringer Ingelheim Investigational Site, Vénissieux

1245.49.49104 Boehringer Ingelheim Investigational Site, Bosenheim

1245.49.49013 Boehringer Ingelheim Investigational Site, Dresden

1245.49.49101 Boehringer Ingelheim Investigational Site, Mainz

1245.49.49002 Boehringer Ingelheim Investigational Site, Neuwied

1245.49.49005 Boehringer Ingelheim Investigational Site, Saarbrücken

1245.49.49102 Boehringer Ingelheim Investigational Site, Wangen

1245.49.50201 Boehringer Ingelheim Investigational Site, Guatemala City

1245.49.50202 Boehringer Ingelheim Investigational Site, Guatemala City

1245.49.50203 Boehringer Ingelheim Investigational Site, Guatemala City

1245.49.50204 Boehringer Ingelheim Investigational Site, Guatemala City

1245.49.50205 Boehringer Ingelheim Investigational Site, Quetzaltenango

1245.49.52011 Boehringer Ingelheim Investigational Site, Aguascalientes

1245.49.52012 Boehringer Ingelheim Investigational Site, Cuautla

1245.49.52003 Boehringer Ingelheim Investigational Site, Durango

1245.49.52005 Boehringer Ingelheim Investigational Site, Durango

1245.49.52004 Boehringer Ingelheim Investigational Site, Guadalajara

1245.49.52006 Boehringer Ingelheim Investigational Site, Guadalajara

1245.49.52008 Boehringer Ingelheim Investigational Site, Guadalajara

1245.49.52001 Boehringer Ingelheim Investigational Site, México, D.F.

1245.49.52002 Boehringer Ingelheim Investigational Site, Monterrey

1245.49.52009 Boehringer Ingelheim Investigational Site, Monterrey

1245.49.52010 Boehringer Ingelheim Investigational Site, Monterrey

1245.49.51002 Boehringer Ingelheim Investigational Site, Arequipa

1245.49.51006 Boehringer Ingelheim Investigational Site, Arequipa

1245.49.51010 Boehringer Ingelheim Investigational Site, Jesus Maria

1245.49.51001 Boehringer Ingelheim Investigational Site, Lima

1245.49.51008 Boehringer Ingelheim Investigational Site, Lima

1245.49.51009 Boehringer Ingelheim Investigational Site, Lima

1245.49.70008 Boehringer Ingelheim Investigational Site, Moscow

1245.49.70009 Boehringer Ingelheim Investigational Site, Moscow

1245.49.70006 Boehringer Ingelheim Investigational Site, Saint Petersburg

1245.49.70010 Boehringer Ingelheim Investigational Site, Saint Petersburg

1245.49.34039 Boehringer Ingelheim Investigational Site, Ávila

1245.49.34038 Boehringer Ingelheim Investigational Site, Madrid

1245.49.34044 Boehringer Ingelheim Investigational Site, Madrid

1245.49.34043 Boehringer Ingelheim Investigational Site, MBoadilla Del Monte (Madrid)

1245.49.34047 Boehringer Ingelheim Investigational Site, Palma de Mallorca

1245.49.34045 Boehringer Ingelheim Investigational Site, Pozuelo de Alarcón

1245.49.34016 Boehringer Ingelheim Investigational Site, Santiago de Compostela (La Coruña)

1245.49.34041 Boehringer Ingelheim Investigational Site, Valencia

1245.49.75016 Boehringer Ingelheim Investigational Site, Kharkiv

1245.49.75007 Boehringer Ingelheim Investigational Site, Kiev

1245.49.75014 Boehringer Ingelheim Investigational Site, Kiev

1245.49.75015 Boehringer Ingelheim Investigational Site, Kiev

1245.49.75013 Boehringer Ingelheim Investigational Site, Kyiv